Mirapro 7.5 7.5 mg tablet is a medicine made by Square Pharmaceuticals PLC. It is an atypical antidepressant that may help relieve symptoms of depression.
There are 20 brands of Mirtazapine listed in Bangladesh. By unit price, Mirapro 7.5 is among the cheapest of them. The lowest listed price is Rapine 7.5 Tablet at ৳ 6 per unit.
What is Mirapro 7.5 Tablet?
Mirapro 7.5 7.5 mg tablet is a medicine made by Square Pharmaceuticals PLC. It is prescribed for adults with major depressive disorder. The exact way Mirtazapine works is not fully known, but it is believed to increase the activity of noradrenaline and serotonin in the brain by blocking certain receptors. The doctor decides the dose and course.
Uses of Mirapro 7.5
It is an atypical antidepressant that may help relieve symptoms of depression. Do not start or stop this medicine without medical advice. It is not a quick fix and is taken as part of a plan your doctor sets up. The doctor decides the dose and how long you need to take it.
How to use Mirapro 7.5
Follow all instructions given by your healthcare provider. Mirapro 7.5 is taken by mouth. Swallow the tablet with water. If you are unsure how to take it, ask your doctor or pharmacist. Do not change the dose or stop early without asking your doctor. If you miss a dose, ask your doctor or pharmacist what to do.
Side effects of Mirapro 7.5
Common side effects of Mirtazapine include dizziness, drowsiness, dry mouth, increased appetite and weight gain. Like all medicines, Mirapro 7.5 can cause side effects. Because it can make you drowsy and affect judgment and motor skills, be careful with activities like driving until you know how it affects you. Do not stop the medicine on your own. Contact your doctor if side effects bother you or do not go away.
Safety and precautions
The medicine may cause drowsiness and affect judgment and motor skills. Because it can cause drowsiness and affect judgment, be careful with driving and skilled tasks. People with a known allergy to Mirtazapine should not use it. Keep out of reach of children.
Frequently asked questions
Why is Mirapro 7.5 prescribed?
It is an atypical antidepressant that may help relieve symptoms of depression. Do not start or stop this medicine without medical advice.
How is Mirapro 7.5 used?
Follow all instructions given by your healthcare provider. Mirapro 7.5 is taken by mouth.
Can Mirapro 7.5 cause side effects?
Common side effects of Mirtazapine include dizziness, drowsiness, dry mouth, increased appetite and weight gain. Like all medicines, Mirapro 7.5 can cause side effects.
Who should be careful with Mirapro 7.5?
The medicine may cause drowsiness and affect judgment and motor skills. Because it can cause drowsiness and affect judgment, be careful with driving and skilled tasks.
Mirtazapine Tablets are indicated for the treatment of major depressive disorder (MDD).
Pharmacology
Pharmacodynamics: The mechanism of action of Mirtazapine as with other drugs effective in the treatment of major depressive disorder is unknown. Evidence gathered in preclinical studies suggests that Mirtazapine enhances central noradrenergic and serotonergic activity. These studies have shown that Mirtazapine acts as an antagonist at central presynaptic α2-adrenergic inhibitory autoreceptors and heteroreceptors, an action that is postulated to result in an increase in central noradrenergic and serotonergic activity. Mirtazapine is a potent antagonist of 5- HT2 and 5-HT3 receptors. Mirtazapine has no significant affinity for the 5-HT1A and 5-HT1B receptors. Mirtazapine is a potent antagonist of histamine (H1) receptors, a property that may explain its prominent sedative effects. Mirtazapine is a moderate peripheral α1-adrenergic antagonist, a property that may explain the occasional orthostatic hypotension reported in association with its use. Mirtazapine is a moderate antagonist at muscarinic receptors, a property that may explain the relatively low incidence of anticholinergic side effects associated with its use.
Pharmacokinetics: After oral administration of Mirtazapine tablets, the active constituent mirtazapine is rapidly and well-absorbed, reaching peak plasma levels after about 2 hours. Binding of mirtazapine to plasma proteins is approximately 85%. The mean half-life of elimination is 20-40 hours; (26 hours in males, 37 hours in females). The half-life of elimination is sufficient to justify once-a-day dosing. Mirtazapine displays linear pharmacokinetics within the recommended dose range. Mirtazapine is extensively metabolized and eliminated via the urine and faeces four days. Major pathways of biotransformation are demethylation and oxidation followed by conjugation.
Dosage & Administration
Adult dose: The recommended starting dose for Mirtazapine tablets is 15 mg/day, administered in a single dose, preferably in the evening or prior to sleep. The effective dose range was generally 15 to 45 mg/day and the patients not responding to the initial 15 mg dose may benefit from dose increases up to a 30 mg to maximum of 45 mg/day. Mirtazapine has an elimination half-life of approximately 20 to 40 hours; therefore, dose changes should be made at intervals of less than 1 to 2 weeks in order to allow sufficient time for the therapeutic response to a given dose.
Use in children: Use in children are not recommended to Mirtazapine.
Missed Dose: If anyone misses a dose of mirtazapine, take it as soon as remember unless it is close to when the next dose is due. If anyone missed a dose of medication and it is close to the time of next dose, skip the missed dose and should take next dose at the regularly scheduled time. One should not take double or more than prescribed dose.
Interaction
Mirtazapine has clinically significant drug-drug interactions with Monoamine Oxidase Inhibitors (MAOI) & other serotonergic drugs such as tryptophan, triptans, linezolid, serotonin reuptake inhibitors, venlafaxine, lithium, tramadol, or St. John's wort. Mirtazapine may interrupt the metabolism or activity of Carbamazepine, Phenytoin or Cimetidine. Patient should avoid Alcohol & Diazepam while taking Mirtazapine.
Contraindications
Hypersensitivity: Mirtazapine is contraindicated in patients with a known hypersensitivity to Mirtazapine or to any of the excipients.
Monoamine Oxidase Inhibitors: The concomitant use of Mirtazapine and a monoamine oxidase (MAO) inhibitor is contraindicated. Mirtazapine should not be used within 14 days of initiating or discontinuing therapy with a monoamine oxidase inhibitor (MAOI).
Side Effects
The most common side effects of Mirtazapine are dizziness, drowsiness, dry mouth, increased appetite, weight gain etc.
Pregnancy & Lactation
Pregnancy Category-C. Patients should be advised to notify their physician if they become pregnant or intend to become pregnant during Mirtazapine therapy. Patients should be advised to notify their physician if they are breastfeeding an infant.
Precautions & Warnings
Patients, their families, and their caregivers should be encouraged to be alert to the emergence of anxiety, agitation, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia (psychomotor restlessness), hypomania, mania, other unusual changes in behavior, worsening of depression, and suicidal ideation, especially early during antidepressant treatment and when the dose is adjusted up or down. Patients who are to receive Mirtazapine should be warned about the risk of developing agranulocytosis. Mirtazapine may impair judgment, thinking, and particularly, motor skills, because of its prominent sedative effect. Clinically significant ALT (SGPT) elevations (≥3 times the upper limit of the normal range) may occur.
Storage Conditions
Keep away from light and moisture. Store below 30º C. Keep all medicine out of the reach of children.
Alternative brands of Mirtazapine
Other brands with the same generic name, cheapest first.